What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us?

被引:136
作者
Menzies, D
机构
[1] McGill Univ, Montreal Chest Inst, Dept Med, Montreal, PQ H2X 2P4, Canada
[2] McGill Univ, Montreal Chest Inst, Dept Epidemiol, Montreal, PQ H2X 2P4, Canada
[3] McGill Univ, Montreal Chest Inst, Dept Biostat, Montreal, PQ H2X 2P4, Canada
关键词
D O I
10.1086/314075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of bacille Calmette-Guerin (BCG) vaccination on tuberculin reactivity is briefly reviewed. BCG vaccination will almost invariably result in tuberculin conversion with a positive tuberculin skin test developing 4-8 weeks after vaccination. However, these tuberculin reactions will wane-rapidly in all individuals who receive the vaccine in the neonatal period and more slowly in those who are vaccinated at an older age such as during the primary-school years. Of BCG vaccine recipients whose initial tuberculin skin test is negative, 10%-25% will have a positive tuberculin skin test if they are retested within 1-4 weeks-the so-called "booster phenomenon." There is no relationship between tuberculin reactivity after BCG vaccination and the protective efficacy of the vaccine against development of active tuberculosis. Therefore, the ideal BCG vaccine would produce a scar at the site of injection to identify individuals who have been vaccinated but would have no effect on tuberculin reactivity.
引用
收藏
页码:S71 / S74
页数:4
相关论文
共 32 条
[1]   DOES THE PROTECTIVE EFFECT OF NEONATAL BCG CORRELATE WITH VACCINE-INDUCED TUBERCULIN REACTION [J].
ALKASSIMI, FA ;
ALHAJJAJ, MS ;
ALORAINEY, IO ;
BAMGBOYE, EA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1575-1578
[2]  
ASHLEY MJ, 1967, CAN MED ASSOC J, V97, P1335
[3]  
Belcourt JP, 1971, S SERIES IMMUNOBIOLO, V17, P85
[4]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[5]  
COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P572
[6]   IDENTIFICATION OF AN EFFECTIVE VACCINE AGAINST TUBERCULOSIS [J].
COMSTOCK, GW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :479-480
[7]  
COMSTOCK GW, 1971, AM REV RESPIR DIS, V103, P572
[8]  
EDWARDS LB, 1973, AM REV RESPIR DIS, V108, P1334
[9]   DELAYED-TYPE HYPERSENSITIVITY, MYCOBACTERIAL VACCINES AND PROTECTIVE IMMUNITY [J].
FINE, PEM ;
STERNE, JAC ;
PONNIGHAUS, JM ;
REES, RJW .
LANCET, 1994, 344 (8932) :1245-1249
[10]  
FRIEDLAND IR, 1990, S AFR MED J, V77, P387